Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-02-20 Sale | 2024-02-21 4:31 pm | Annexon Inc. | ANNX | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | 2,593 | $5.53 | $14,339 | 242,058 (Direct) | View |
2024-02-20 Sale | 2024-02-21 4:31 pm | Annexon Inc. | ANNX | Yednock Ted EVP & CHIEF INNOVATION OFFICER | 2,604 | $5.51 | $14,348 | 253,471 (Indirect Direct) | View |
2024-02-20 Sale | 2024-02-21 4:31 pm | Annexon Inc. | ANNX | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | 1,951 | $5.48 | $10,691 | 245,641 (Direct) | View |
2024-02-12 Sale | 2024-02-14 7:59 pm | Annexon Inc. | ANNX | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | 1,349 | $5.53 | $7,460 | 48,592 (Direct) | View |
2024-02-12 Sale | 2024-02-14 7:56 pm | Annexon Inc. | ANNX | Love Douglas PRESIDENT AND CEO | 5,782 | $5.54 | $32,032 | 196,121 (Direct) | View |
2024-02-12 Sale | 2024-02-14 7:54 pm | Annexon Inc. | ANNX | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | 1,809 | $5.54 | $10,022 | 45,651 (Direct) | View |
2024-02-12 Sale | 2024-02-14 7:52 pm | Annexon Inc. | ANNX | Yednock Ted EVP & CHIEF INNOVATION OFFICER | 1,810 | $5.54 | $10,027 | 57,075 (Indirect Direct) | View |
2023-07-11 Sale(A) | 2024-01-23 5:00 pm | Annexon Inc. | ANNX | Yednock Ted EVP & Chief Innovation Officer | 22,057 | $4.4893 | $99,021 | 58,885 (Indirect Direct) | View |
2023-07-11 Sale | 2024-01-23 4:58 pm | Annexon Inc. | ANNX | Overdorf Michael EVP & Chief Business Officer | 978 | $3.8361 | $3,752 | 45,802 (Direct) | View |
2023-07-11 Sale | 2024-01-23 4:57 pm | Annexon Inc. | ANNX | Lew Jennifer EVP & Chief Financial Officer | 1,057 | $3.8361 | $4,055 | 47,460 (Direct) | View |
2023-12-27 Sale | 2023-12-29 4:12 pm | Annexon Inc. | ANNX | Yednock Ted EVP & Chief Innovation Officer | 21,000 | $4.5222 | $94,966 | 36,000 (Direct) | View |
2023-12-26 Purchase | 2023-12-28 4:30 pm | Annexon Inc. | ANNX | Satter Muneer A Director 10% Owner | 350,000 | $2.88 | $1,008,000 | 7,406,024 (Indirect) | View |
2023-05-25 Purchase | 2023-05-30 9:54 pm | Annexon Inc. | ANNX | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Fund L.P. Bain Capital Life Sciences Partners LP BCIP Life Sciences Associates LP 10% Owner | 300,000 | $2.1324 | $639,720 | 5,701,926 (Indirect) | View |
2023-02-15 Sale | 2023-02-17 5:12 pm | Annexon Inc. | ANNX | Love Douglas President & CEO | 6,571 | $5.8688 | $38,564 | 197,646 (Direct) | View |
2023-02-13 Sale | 2023-02-15 7:00 pm | Annexon Inc. | ANNX | Overdorf Michael EVP & Chief Business Officer | 1,645 | $6.3029 | $10,368 | 27,805 (Direct) | View |
2023-02-13 Sale | 2023-02-15 6:59 pm | Annexon Inc. | ANNX | Lew Jennifer EVP & Chief Financial Officer | 1,908 | $6.3077 | $12,035 | 29,542 (Direct) | View |
2023-02-10 Purchase | 2023-02-14 4:31 pm | Annexon Inc. | ANNX | Satter Muneer A Director 10% Owner | 2,647,058 | $6.8 | $17,999,994 | 7,056,024 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-02-16 Option Award | 2024-02-21 4:32 pm | N/A 2034-02-16 | Annexon Inc. | ANNX | Love Douglas PRESIDENT AND CEO | 656,200 | $0 | 656,200 (Direct) | View |
2024-02-16 Option Award | 2024-02-21 4:32 pm | N/A 2034-02-16 | Annexon Inc. | ANNX | Dananberg Jamie CHIEF MEDICAL OFFICER | 199,000 | $0 | 199,000 (Direct) | View |
2024-02-16 Option Award | 2024-02-21 4:32 pm | N/A 2034-02-16 | Annexon Inc. | ANNX | ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER | 199,000 | $0 | 249,329 (Direct) | View |
2024-02-16 Option Award | 2024-02-21 4:31 pm | N/A 2034-02-16 | Annexon Inc. | ANNX | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | 199,000 | $0 | 242,058 (Direct) | View |
2024-02-16 Option Award | 2024-02-21 4:31 pm | N/A 2034-02-16 | Annexon Inc. | ANNX | Yednock Ted EVP & CHIEF INNOVATION OFFICER | 199,000 | $0 | 253,471 (Direct) | View |
2024-02-16 Option Award | 2024-02-21 4:31 pm | N/A 2034-02-16 | Annexon Inc. | ANNX | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | 199,000 | $0 | 245,641 (Direct) | View |
2023-12-27 Exercise(A) | 2024-01-23 5:00 pm | N/A N/A | Annexon Inc. | ANNX | Yednock Ted EVP & Chief Innovation Officer | 10,615 | $1.4096 | 58,885 (Direct) | View |
2023-12-27 Exercise(A) | 2024-01-23 5:00 pm | N/A N/A | Annexon Inc. | ANNX | Yednock Ted EVP & Chief Innovation Officer | 10,385 | $1.8501 | 58,885 (Direct) | View |
2023-12-27 Exercise | 2023-12-29 4:12 pm | N/A 2025-01-22 | Annexon Inc. | ANNX | Yednock Ted EVP & Chief Innovation Officer | 21,000 | $0 | 36,000 (Direct) | View |
2023-12-27 Exercise | 2023-12-29 4:12 pm | N/A N/A | Annexon Inc. | ANNX | Yednock Ted EVP & Chief Innovation Officer | 10,615 | $1.4096 | 36,000 (Direct) | View |
2023-12-27 Exercise | 2023-12-29 4:12 pm | N/A N/A | Annexon Inc. | ANNX | Yednock Ted EVP & Chief Innovation Officer | 10,385 | $1.8501 | 36,000 (Direct) | View |
2023-08-01 Option Award | 2023-08-02 5:07 pm | N/A 2033-08-01 | Annexon Inc. | ANNX | Dananberg Jamie Chief Medical Officer | 275,000 | $0 | 275,000 (Direct) | View |
2023-06-08 Option Award | 2023-06-12 5:52 pm | N/A 2033-06-08 | Annexon Inc. | ANNX | Satter Muneer A Director 10% Owner | 24,000 | $0 | 24,000 (Direct) | View |
2023-06-08 Option Award | 2023-06-12 4:50 pm | N/A 2033-06-08 | Annexon Inc. | ANNX | WIGGANS THOMAS G Director | 24,000 | $0 | 24,000 (Direct) | View |
2023-06-08 Option Award | 2023-06-12 4:49 pm | N/A 2033-06-08 | Annexon Inc. | ANNX | Choi Jung Director | 24,000 | $0 | 24,000 (Direct) | View |
2023-06-08 Option Award | 2023-06-12 4:48 pm | N/A 2033-06-08 | Annexon Inc. | ANNX | Cockroft Bettina M. Director | 24,000 | $0 | 24,000 (Direct) | View |
2023-06-08 Option Award | 2023-06-12 4:45 pm | N/A 2033-06-08 | Annexon Inc. | ANNX | Waddill William D. Director | 24,000 | $0 | 24,000 (Direct) | View |
2023-06-08 Option Award | 2023-06-12 4:44 pm | N/A 2033-06-08 | Annexon Inc. | ANNX | Carson William H. Director | 24,000 | $0 | 24,000 (Direct) | View |
Ownership | 2023-05-30 9:55 pm | N/A N/A | Annexon Inc. | ANNX | Bain Capital Life Sciences Investors LLC Bain Capital Life Sciences Fund L.P. Bain Capital Life Sciences Partners LP BCIP Life Sciences Associates LP 10% Owner | 0 | $0 | 8,916,344 (Indirect) | View |
Ownership | 2023-03-27 5:44 pm | N/A N/A | Annexon Inc. | ANNX | Yednock Ted EVP & Chief Innovation Officer | 0 | $0 | 744,947 (Direct) | View |
2023-02-16 Option Award | 2023-02-21 5:28 pm | N/A 2033-02-16 | Annexon Inc. | ANNX | Love Douglas President & CEO | 345,000 | $0 | 345,000 (Direct) | View |
2023-02-16 Option Award | 2023-02-21 5:27 pm | N/A 2033-02-16 | Annexon Inc. | ANNX | Overdorf Michael EVP & Chief Business Officer | 96,025 | $0 | 123,830 (Direct) | View |
2023-02-16 Option Award | 2023-02-21 5:26 pm | N/A 2033-02-16 | Annexon Inc. | ANNX | Lew Jennifer EVP & Chief Financial Officer | 96,025 | $0 | 125,567 (Direct) | View |
2023-01-15 Option Award | 2023-01-18 7:43 pm | N/A 2033-01-15 | Annexon Inc. | ANNX | ARTIS DEAN RICHARD EVP & Chief Scientific Officer | 210,000 | $0 | 210,000 (Direct) | View |
Ownership | 2023-01-12 4:40 pm | N/A N/A | Annexon Inc. | ANNX | ARTIS DEAN RICHARD EVP & Chief Scientific Officer | 0 | $0 | 147,295 (Direct) | View |
2022-07-11 Option Award | 2022-07-13 7:49 pm | N/A 2032-07-11 | Annexon Inc. | ANNX | Overdorf Michael EVP & Chief Business Officer | 84,375 | $0 | 96,875 (Direct) | View |
2022-07-11 Option Award | 2022-07-13 7:46 pm | N/A 2032-07-11 | Annexon Inc. | ANNX | Love Douglas President & CEO | 300,000 | $0 | 300,000 (Direct) | View |
2022-07-11 Option Award | 2022-07-13 7:40 pm | N/A 2032-07-11 | Annexon Inc. | ANNX | Mattheakis Larry EVP & Chief Scientific Officer | 42,188 | $0 | 54,688 (Direct) | View |
2022-07-11 Option Award | 2022-07-13 7:37 pm | N/A 2032-07-11 | Annexon Inc. | ANNX | Mattheakis Larry EVP & Chief Scientific Officer | 42,188 | $0 | 54,688 (Direct) | View |
2022-07-11 Option Award | 2022-07-13 7:05 pm | N/A 2032-07-11 | Annexon Inc. | ANNX | Love Douglas President & CEO | 300,000 | $0 | 300,000 (Direct) | View |